What are the major opportunities in the Mid-Size Pharmaceuticals market? What are the strategies for the Mid-Size Pharmaceuticals market?

For detailed insights on the major opportunities and strategies in the Mid-Size Pharmaceuticals market, Read More

How does the Mid-Size Pharmaceuticals market relate to the overall economy and other similar markets?

For detailed insights on Mid-Size Pharmaceuticals's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Mid-Size Pharmaceuticals market growth? SWOT analysis of the Mid-Size Pharmaceuticals market.

For detailed insights on the key dynamics influencing the Mid-Size Pharmaceuticals market growth and SWOT analysis of the Mid-Size Pharmaceuticals industry, Read More

Global Mid-Size Pharmaceuticals Market Report 2025

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Mid-Size Pharmaceuticals Global Market Report 2025

Name: Mid-Size Pharmaceuticals Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Development Type (In-House, Outsource), By Type (Prescription, Over the Counter), By Formulation (Tablets, Capsules, Injectables, Sprays, Other Formulations), By Application (Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Mid-Size Pharmaceuticals Market Overview

• Mid-Size Pharmaceuticals market size has reached to $718.71 billion in 2024

• Expected to grow to $983.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%

• Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Growth In Mid-Size Pharmaceuticals Market

• Market Trend: Technology Advancements Shaping The Mid-Size Pharmaceuticals Market

• North America was the largest region in 2024.

What Is Covered Under Mid-Size Pharmaceuticals Market?

Mid-sized pharmaceuticals are companies with annual revenue ranging from $1 billion to $10 billion. Mid-sized pharmaceutical companies include drug development, niche market targeting, regional presence, partnerships, generic drug manufacturing, and contract manufacturing.

The main types of drug development of mid-size pharmaceuticals are in-house and outsourced. In-house refers to activities or functions performed within an organization or company by its employees or departments rather than outsourcing them to external parties or contractors. In-house in mid-size pharmaceuticals refers to the activities or functions that are conducted internally within the pharmaceutical company by its employees or departments, rather than being outsourced to external entities. This can include various functions such as research and development, manufacturing, quality control, regulatory affairs, sales and marketing, and other operational aspects of the pharmaceutical business. It has prescription and over-the-counter facilities that sell medicines in the form of tablets, capsules, injectables, sprays, and others that are suitable for treating cardiovascular diseases, Pain Management, diabetes, cancer, and others.

Mid-Size Pharmaceuticals Market Size and growth rate 2025 to 2029: Graph

What Is The Mid-Size Pharmaceuticals Market Size 2025 And Growth Rate?

What Is The Mid-Size Pharmaceuticals Market Growth Forecast?

The mid-size pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $983.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to a growing shift towards value-based care models, regulatory pathway streamlining, increased health awareness and patient empowerment, demand for generic and biosimilar drugs, emergence of digital therapeutics. Major trends in the forecast period include an increased focus on patient-centric approaches, the adoption of artificial intelligence (AI), global market expansion strategies, environmental sustainability initiatives, telemedicine, and remote patient monitoring.

The forecast of 6.6% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder specialty pharma companies by inflating prices of niche therapeutic formulation equipment and blister packaging systems sourced from Germany and Japan, resulting in reduced competitiveness against large pharma and higher patient access barriers. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Mid-Size Pharmaceuticals Market Segmented?

1) By Drug Development Type: In-House, Outsource

2) By Type: Prescription, Over The Counter

3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations

4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions

Subsegments:

1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management

2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)

What Is Driving The Mid-Size Pharmaceuticals Market? Rising Prevalence Of Chronic Diseases Fuels Growth In Mid-Size Pharmaceuticals Market

The increased prevalence of chronic diseases is expected to propel the growth of mid-size pharmaceuticals market going forward. Chronic diseases, also known as non-communicable diseases, are long-term medical conditions that require ongoing management and treatment which leads to high demand for medications. Mass spectrometry techniques are used for the identification, quantification, and analysis of biomarkers and metabolites associated with chronic diseases. A rise in the prevalence of chronic diseases will contribute to the growth of the mid-size pharmaceuticals market. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Therefore, the increasing prevalence of chronic diseases is driving the growth of the mid-size pharmaceuticals industry.

What Is Driving The Mid-Size Pharmaceuticals Market? Healthcare Expenditure Boosting Growth In Midsize Pharmaceutical Market

The increasing healthcare expenditure is expected to propel the growth of the midsized pharmaceutical market. Healthcare refers to the organized provision of medical care, preventive services, diagnostic testing, treatment, and support services to individuals and communities to maintain and improve overall health. Higher healthcare spending often leads to increased investment in research and development within the pharmaceutical industry. Mid-sized pharmaceutical companies may benefit from this investment, allowing them to develop and bring new drugs to market. For instance, in the Economic Survey of 2022, an annual document of the Ministry of Finance, Government of India, India’s public expenditure on healthcare stood at 2.1% of GDP in 2021–22. Moreover, according to a survey of global medical insurers conducted by Willis Towers Watson Public Limited Company, a British-American company providing insurance services, healthcare benefit costs increased to 8.8% in 2022 and are expected to grow again in 2023 to a high global average of 10%. Therefore, the increased healthcare expenditure will drive the growth of the midsized pharmaceutical market.

Who Are The Major Players In The Global Mid-Size Pharmaceuticals Market?

Major companies operating in the mid-size pharmaceuticals market include Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.

What Are The Key Trends Of The Global Mid-Size Pharmaceuticals Market? Technology Advancements Shaping The Mid-Size Pharmaceuticals Market

Technology advancements are a key trend gaining popularity in the mid-size pharmaceuticals market. Major companies operating in the mid-size pharmaceuticals market are using technology to sustain their position in the market. For Instance, In May 2023, Google Cloud, offered by Google, a US-based suite of cloud computing services, launched AI-powered tools to accelerate drug discovery and precision medicine. One instrument, the Target and Lead Identification Suite assists businesses in foreseeing and comprehending protein structure, a crucial aspect of drug research. The Multiomics Suite is another tool that will help researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data.

What Are The Key Trends Of The Global Mid-Size Pharmaceuticals Market? Mid-Size Pharmaceuticals Embrace Precision Medicine With Innovative Platforms

Major companies operating in mid-size pharmaceuticals are focusing on product development and launches such as precision medicine platforms to sustain their position in the market. A precision medicine platform refers to an advanced technology or system designed to tailor medical treatment and interventions to the specific characteristics of individual patients. For instance, in February 2023, C4X Discovery Holdings PLC, a UK-based mid-size pharmaceutical company, unveiled its innovative precision medicine platform, PatientSeek. This platform is designed to identify patients who are most likely to benefit from a specific medication based on their genetic makeup. The launch of PatientSeek follows successful validation in patient stratification, where a subgroup of patients responding positively to treatment was identified during a retrospective analysis of a Phase 3 clinical trial for Parkinson's disease. This development marks a significant step in leveraging genetics for targeted and effective medication strategies, showcasing the potential of precision medicine in optimizing treatment outcomes.

Need data on a specific region in this market?

Request Regional Data

Mid-Size Pharmaceuticals Market Merger And Acquisition: Sun Pharmaceutical Boosts Pipeline With Strategic Concert Pharmaceuticals Acquisition

In March 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 Million. Through this acquisition, Sun Pharmaceutical Industries Limited gains all outstanding shares of Concert’s common stock and the addition of deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia areata to its pipeline. Concert Pharmaceuticals Inc. is a US-based late-stage clinical mid-sized biopharmaceutical company developing innovative medicines with unique therapeutic properties.

Regional Outlook For The Global Mid-Size Pharmaceuticals Market

North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mid-Size Pharmaceuticals Market?

The mid-sized pharmaceuticals market consists of revenues earned by entities providing pharmaceutical services such as drug development, research activities, generic drug manufacturing, and contract manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The mid-sized pharmaceuticals market consists of the sales of goods such as prescription drugs, over-the-counter medications, generic drugs, and other pharmaceutical products targeting specific therapeutic areas or niche markets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Mid-Size Pharmaceuticals Industry?

The mid-size pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mid-size pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Mid-Size Pharmaceuticals Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$760.71 billion
Revenue Forecast In 2034	$983.81 billion
Growth Rate	CAGR of 6.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Development Type: In-House, Outsource 2) By Type: Prescription, Over The Counter 3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations 4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions Subsegments: 1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management 2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs)
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Alexion Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Wuxi AppTec co. Ltd., Les Laboratoires Servier S.A., Hospira Inc., Perrigo Co Plc, Aurobindo Pharma Lmited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co. Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt Plc, Exelixis Inc., Mylan Pharmaceuticals Inc., Neurocrine Biosciences Inc., Kyowa Kirin Co. Ltd., Emergent BioSolutions Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Mid-Size Pharmaceuticals Market Characteristics

3. Mid-Size Pharmaceuticals Market Trends And Strategies

4. Mid-Size Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mid-Size Pharmaceuticals Growth Analysis And Strategic Analysis Framework

5.1. Global Mid-Size Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Mid-Size Pharmaceuticals Market Growth Rate Analysis

5.4. Global Mid-Size Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Mid-Size Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Mid-Size Pharmaceuticals Total Addressable Market (TAM)

6. Mid-Size Pharmaceuticals Market Segmentation

6.1. Global Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In-House

Outsource

6.2. Global Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prescription

Over The Counter

6.3. Global Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Injectables

Sprays

Other Formulations

6.4. Global Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cardiovascular Diseases

Pain Management

Diabetes

Cancer

Other Conditions

6.5. Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of In-House, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research And Development (R&D) Departments

Clinical Trials Management

6.6. Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of Outsource, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Contract Research Organizations (CROs)

Contract Manufacturing Organizations (CMOs)

7. Mid-Size Pharmaceuticals Market Regional And Country Analysis

7.1. Global Mid-Size Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Mid-Size Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mid-Size Pharmaceuticals Market

8.1. Asia-Pacific Mid-Size Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mid-Size Pharmaceuticals Market

9.1. China Mid-Size Pharmaceuticals Market Overview

9.2. China Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mid-Size Pharmaceuticals Market

10.1. India Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mid-Size Pharmaceuticals Market

11.1. Japan Mid-Size Pharmaceuticals Market Overview

11.2. Japan Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mid-Size Pharmaceuticals Market

12.1. Australia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mid-Size Pharmaceuticals Market

13.1. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mid-Size Pharmaceuticals Market

14.1. South Korea Mid-Size Pharmaceuticals Market Overview

14.2. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mid-Size Pharmaceuticals Market

15.1. Western Europe Mid-Size Pharmaceuticals Market Overview

15.2. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mid-Size Pharmaceuticals Market

16.1. UK Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mid-Size Pharmaceuticals Market

17.1. Germany Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mid-Size Pharmaceuticals Market

18.1. France Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mid-Size Pharmaceuticals Market

19.1. Italy Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mid-Size Pharmaceuticals Market

20.1. Spain Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mid-Size Pharmaceuticals Market

21.1. Eastern Europe Mid-Size Pharmaceuticals Market Overview

21.2. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mid-Size Pharmaceuticals Market

22.1. Russia Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mid-Size Pharmaceuticals Market

23.1. North America Mid-Size Pharmaceuticals Market Overview

23.2. North America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mid-Size Pharmaceuticals Market

24.1. USA Mid-Size Pharmaceuticals Market Overview

24.2. USA Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mid-Size Pharmaceuticals Market

25.1. Canada Mid-Size Pharmaceuticals Market Overview

25.2. Canada Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mid-Size Pharmaceuticals Market

26.1. South America Mid-Size Pharmaceuticals Market Overview

26.2. South America Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mid-Size Pharmaceuticals Market

27.1. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mid-Size Pharmaceuticals Market

28.1. Middle East Mid-Size Pharmaceuticals Market Overview

28.2. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mid-Size Pharmaceuticals Market

29.1. Africa Mid-Size Pharmaceuticals Market Overview

29.2. Africa Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mid-Size Pharmaceuticals Market Competitive Landscape And Company Profiles

30.1. Mid-Size Pharmaceuticals Market Competitive Landscape

30.2. Mid-Size Pharmaceuticals Market Company Profiles

30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Otsuka Pharmaceutical Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Daiichi Sankyo Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Mid-Size Pharmaceuticals Market Other Major And Innovative Companies

31.1. Alexion Pharmaceuticals Inc.

31.2. UCB S.A.

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Eisai Co. Ltd.

31.5. Wuxi AppTec co. Ltd.

31.6. Les Laboratoires Servier S.A.

31.7. Hospira Inc.

31.8. Perrigo Co Plc

31.9. Aurobindo Pharma Lmited.

31.10. Cipla Limited

31.11. Hikma Pharmaceuticals

31.12. Endo International plc

31.13. Taisho Pharmaceutical Holdings Co. Ltd.

31.14. BioMarin Pharmaceutical Inc.

31.15. Mallinckrodt Plc

32. Global Mid-Size Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mid-Size Pharmaceuticals Market

34. Recent Developments In The Mid-Size Pharmaceuticals Market

35. Mid-Size Pharmaceuticals Market High Potential Countries, Segments and Strategies

35.1 Mid-Size Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities

35.2 Mid-Size Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities

35.3 Mid-Size Pharmaceuticals Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of In-House, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of Outsource, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Mid-Size Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Mid-Size Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Baxter International Inc. Financial Performance

Table 78: Teva Pharmaceutical Industries Ltd. Financial Performance

Table 79: Otsuka Pharmaceutical Co Ltd. Financial Performance

Table 80: Astellas Pharma Inc. Financial Performance

Table 81: Daiichi Sankyo Co. Ltd. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Mid-Size Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of In-House, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Mid-Size Pharmaceuticals Market, Sub-Segmentation Of Outsource, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Mid-Size Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Mid-Size Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Drug Development Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Mid-Size Pharmaceuticals Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Baxter International Inc. Financial Performance

Figure 78: Teva Pharmaceutical Industries Ltd. Financial Performance

Figure 79: Otsuka Pharmaceutical Co Ltd. Financial Performance

Figure 80: Astellas Pharma Inc. Financial Performance

Figure 81: Daiichi Sankyo Co. Ltd. Financial Performance

2025 Over-The-Counter (OTC) Diet Products Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Parathyroid Disease Treatment Market Revenue Outlook: Strategic Insights and Forecast to 2029

Industry Forecast: PCSK9 Inhibitor Market to Generate $6.87 Billion Revenue by 2029

CAGR of 5.4% Projected for Pediatric Asthma Treatment Market From 2025 to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – By Type (Synthetic, Chemical, Biological), By Therapeutic Type (Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular...

View Report

Pharmaceutical Drug Delivery Global Market Report 2025 – By Route of Administration (Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes), By Application (Infectious Diseases, Cancer, Cardiovascular Disease...

View Report

Pharmaceutical Chemicals Global Market Report 2025 – By Product Type (Solvents, Reagents Or Catalysts, KSMs Or Intermediates, Building Blocks For APIs Or Advanced Intermediates), By Drug Type (Proprietary, Non-Proprietar...

View Report

Small Molecule Injectable Drugs Global Market Report 2025 – By Drug Class (Small Molecule Antibiotics, Analgesics, Chemotherapy, Antivirals, Anticoagulant, Skeletal Muscle Relaxants, Anticonvulsants, Other Drug Class), B...

View Report

Drug Formulation Global Market Report 2025 – By Dosage Form (Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions,...

View Report

Pharmaceutical Packaging Equipment Global Market Report 2025 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterilization Equipment), By Packaging Type (Liquids Packaging Equipmen...

View Report

Mid-Size Pharmaceuticals Global Market Report 2025 – By Drug Development Type (In-House, Outsource), By Type (Prescription, Over the Counter), By Formulation (Tablets, Capsules, Injectables, Sprays, Other Formulations), ...

View Report

Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective...

View Report

Frequently Asked Questions

What is the definition of the Mid-Size Pharmaceuticals market?

How will the Mid-Size Pharmaceuticals market drivers and restraints affect the market dynamics? What forces will shape the Mid-Size Pharmaceuticals industry going forward?

The market major growth driver - Rising Prevalence Of Chronic Diseases Fuels Growth In Mid-Size Pharmaceuticals Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Mid-Size Pharmaceuticals market?

The mid-size pharmaceuticals market size has grown strongly in recent years. It will grow from $718.71 billion in 2024 to $760.71 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to generic drug market growth, patent expirations of blockbuster drugs, healthcare cost containment measures, biotechnology expansion, and regulatory changes encouraging innovation The mid-size pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to " $983.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to a growing shift towards value-based care models, regulatory pathway streamlining, increased health awareness and patient empowerment, demand for generic and biosimilar drugs, emergence of digital therapeutics. Major trends in the forecast period include an increased focus on patient-centric approaches, the adoption of artificial intelligence (AI), global market expansion strategies, environmental sustainability initiatives, telemedicine, and remote patient monitoring. For further insights on this market, request a sample here

How is the Mid-Size Pharmaceuticals market segmented?

The mid-size pharmaceuticals market covered in this report is segmented –
1) By Drug Development Type: In-House, Outsource
2) By Type: Prescription, Over The Counter
3) By Formulation: Tablets, Capsules, Injectables, Sprays, Other Formulations
4) By Application: Cardiovascular Diseases, Pain Management, Diabetes, Cancer, Other Conditions Subsegments:
1) By In-House: Research And Development (R&D) Departments, Clinical Trials Management
2) By Outsource: Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) For further insights on this market, request a sample here

Which region has the largest share of the Mid-Size Pharmaceuticals market? What are the other regions covered in the report?

North America was the largest region in the mid-size pharmaceutical market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mid-size pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Mid-Size Pharmaceuticals market?

What are the key trends in the Mid-Size Pharmaceuticals market?

Major trends in this market include Technology Advancements Shaping The Mid-Size Pharmaceuticals Market. For further insights on this market, request a sample here.

Book your 30 minutes free consultation with our research experts

Mid-Size Pharmaceuticals Global Market Report 2025

Mid-Size Pharmaceuticals Market Overview

What Is Covered Under Mid-Size Pharmaceuticals Market?

What Is The Mid-Size Pharmaceuticals Market Size 2025 And Growth Rate?

What Is The Mid-Size Pharmaceuticals Market Growth Forecast?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Mid-Size Pharmaceuticals Market Segmented?

What Is Driving The Mid-Size Pharmaceuticals Market? Rising Prevalence Of Chronic Diseases Fuels Growth In Mid-Size Pharmaceuticals Market

What Is Driving The Mid-Size Pharmaceuticals Market? Healthcare Expenditure Boosting Growth In Midsize Pharmaceutical Market

Who Are The Major Players In The Global Mid-Size Pharmaceuticals Market?

What Are The Key Trends Of The Global Mid-Size Pharmaceuticals Market? Technology Advancements Shaping The Mid-Size Pharmaceuticals Market

What Are The Key Trends Of The Global Mid-Size Pharmaceuticals Market? Mid-Size Pharmaceuticals Embrace Precision Medicine With Innovative Platforms

Mid-Size Pharmaceuticals Market Merger And Acquisition: Sun Pharmaceutical Boosts Pipeline With Strategic Concert Pharmaceuticals Acquisition

Regional Outlook For The Global Mid-Size Pharmaceuticals Market

What Defines the Mid-Size Pharmaceuticals Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Mid-Size Pharmaceuticals Industry?

Mid-Size Pharmaceuticals Market Report Forecast Analysis

Table Of Contents

List Of Tables

List Of Figures

Frequently Asked Questions